Icon, the Dublin-based drug testing company, has said that the Covid-19 pandemic will have a significant impact on its revenues, costing it almost €110 million this quarter.
Icon, which conducts clinical drug trials on behalf of major pharmaceutical companies, has said the measures put in place to close non-essential workplaces has meant that many of the third party sites it works with are currently closed.
Although some drug trials can take place off-site the closure...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team